CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Netflix released its first What We Watched report which ranks nearly all of its movies and shows by the amount of hours viewed within the past six months.
Shawn Fain, the international president of the United Auto Workers union who recently won large raises for his workers, is taking aim at a new target: New Jersey lawmakers who are delaying votes on a bill to ban smoking in Atlantic City’s casinos.
